SURMOUNT-5 added another critical data point by directly comparing tirzepatide to semaglutide, which was previously considered the gold standard among GLP-1 agonists
GLP-1 receptor agonists have shown promising effects on hepatic steatosis in clinical studies, making them potentially therapeutic for this condition as well.[9] However, rapid weight loss one of the well-known effects of GLP-1 therapy is also a known risk factor for gallstone formation, a point that deserves explicit discussion with your physician
Because it's like, if I give you glutathione by itself, then once it quenches all the free radicals, you're done
They can provide personalized guidance on whether this innovative approach might be right for you, taking into account your overall health profile and specific needs
The provider will review your health information and decide whether to issue a prescription